ClearSight LLC has developed the ClearSight Intraocular Lens (IOL), a groundbreaking device aimed at addressing the issue of posterior capsule opacification (PCO), a common complication following cataract surgery. The ClearSight IOL incorporates a unique Sharklet micropattern, which is designed to redirect cellular migration away from the lens, significantly reducing the likelihood of PCO formation. This innovative lens platform is compatible with a variety of premium optics, enhancing patient satisfaction by meeting the increasing expectations for visual outcomes. Additionally, the IOL is constructed from a patented hydrophobic acrylic material that eliminates glistenings, a common issue in leading IOLs that can compromise visual quality.

The ClearSight IOL's design features a 360-degree square-edge micropatterned membrane that effectively prevents lens epithelial cell (LEC) migration, which is responsible for PCO. In vitro studies have shown an 80% reduction in LEC migration, while in vivo studies demonstrated a complete elimination of visually significant PCO in rabbit models. This advancement represents a significant breakthrough in the prevention of lens opacification, potentially transforming the standard of care in cataract surgery. The company's commitment to research and development is further supported by a team of experienced professionals, including experts in ophthalmology and medical device development, who are dedicated to bringing this innovative technology to market.

Denmark

We help organisations and people with important missions to develop and aspire. That's it.

International Organisational Development & Organisational Assessment.

Most endorsed for...

100+ Organizational Development

100+ Talent Management

98 Human Resources

71 Performance Management

65 Change Management

65 Employee Relations

54 Personnel Management

36 Management

34 Management Consulting

ClearSight Fast Forward

Company Details